These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 20717703)

  • 1. In vivo and in vitro inhibition of mice thioredoxin reductase by methylmercury.
    Wagner C; Sudati JH; Nogueira CW; Rocha JB
    Biometals; 2010 Dec; 23(6):1171-7. PubMed ID: 20717703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of the thioredoxin system in the brain and liver of zebra-seabreams exposed to waterborne methylmercury.
    Branco V; Canário J; Holmgren A; Carvalho C
    Toxicol Appl Pharmacol; 2011 Mar; 251(2):95-103. PubMed ID: 21168431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mercury and selenium interaction in vivo: effects on thioredoxin reductase and glutathione peroxidase.
    Branco V; Canário J; Lu J; Holmgren A; Carvalho C
    Free Radic Biol Med; 2012 Feb; 52(4):781-93. PubMed ID: 22198265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of Mammalian thioredoxin reductase by some flavonoids: implications for myricetin and quercetin anticancer activity.
    Lu J; Papp LV; Fang J; Rodriguez-Nieto S; Zhivotovsky B; Holmgren A
    Cancer Res; 2006 Apr; 66(8):4410-8. PubMed ID: 16618767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of both thioredoxin reductase and glutathione reductase may contribute to the anticancer mechanism of TH-302.
    Li S; Zhang J; Li J; Chen D; Matteucci M; Curd J; Duan JX
    Biol Trace Elem Res; 2010 Sep; 136(3):294-301. PubMed ID: 19838642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclophosphamide as a potent inhibitor of tumor thioredoxin reductase in vivo.
    Wang X; Zhang J; Xu T
    Toxicol Appl Pharmacol; 2007 Jan; 218(1):88-95. PubMed ID: 17156807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular bases of thioredoxin and thioredoxin reductase-mediated prooxidant actions of (-)-epigallocatechin-3-gallate.
    Zhang H; Cao D; Cui W; Ji M; Qian X; Zhong L
    Free Radic Biol Med; 2010 Dec; 49(12):2010-8. PubMed ID: 20951799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of selenite and chelating agents on mammalian thioredoxin reductase inhibited by mercury: implications for treatment of mercury poisoning.
    Carvalho CM; Lu J; Zhang X; Arnér ES; Holmgren A
    FASEB J; 2011 Jan; 25(1):370-81. PubMed ID: 20810785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On the potential of thioredoxin reductase inhibitors for cancer therapy.
    Urig S; Becker K
    Semin Cancer Biol; 2006 Dec; 16(6):452-65. PubMed ID: 17056271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small molecule inhibitors of mammalian thioredoxin reductase.
    Cai W; Zhang L; Song Y; Wang B; Zhang B; Cui X; Hu G; Liu Y; Wu J; Fang J
    Free Radic Biol Med; 2012 Jan; 52(2):257-65. PubMed ID: 22064364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of thioredoxin reductase but not of glutathione reductase by the major classes of alkylating and platinum-containing anticancer compounds.
    Witte AB; Anestål K; Jerremalm E; Ehrsson H; Arnér ES
    Free Radic Biol Med; 2005 Sep; 39(5):696-703. PubMed ID: 16085187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diphenyl diselenide, a simple organoselenium compound, decreases methylmercury-induced cerebral, hepatic and renal oxidative stress and mercury deposition in adult mice.
    de Freitas AS; Funck VR; Rotta Mdos S; Bohrer D; Mörschbächer V; Puntel RL; Nogueira CW; Farina M; Aschner M; Rocha JB
    Brain Res Bull; 2009 Apr; 79(1):77-84. PubMed ID: 19047014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of thioredoxin reductase by mansonone F analogues: Implications for anticancer activity.
    Liu Z; Huang SL; Li MM; Huang ZS; Lee KS; Gu LQ
    Chem Biol Interact; 2009 Jan; 177(1):48-57. PubMed ID: 18822278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In Vitro Assessment of the Efficacy of a Macrocyclic Chelator in Reversing Methylmercury Toxicity.
    Nobre P; Cabral MF; Costa J; Castro-Caldas M; Carvalho C; Branco V
    Int J Environ Res Public Health; 2019 Nov; 16(23):. PubMed ID: 31801208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thioredoxin system inhibitors as mediators of apoptosis for cancer therapy.
    Tonissen KF; Di Trapani G
    Mol Nutr Food Res; 2009 Jan; 53(1):87-103. PubMed ID: 18979503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sublethal concentrations of diverse gold compounds inhibit mammalian cytosolic thioredoxin reductase (TrxR1).
    Omata Y; Folan M; Shaw M; Messer RL; Lockwood PE; Hobbs D; Bouillaguet S; Sano H; Lewis JB; Wataha JC
    Toxicol In Vitro; 2006 Sep; 20(6):882-90. PubMed ID: 16510263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High redox thioredoxin but low thioredoxin reductase activities in the serum of patients with rheumatoid arthritis.
    Lemarechal H; Allanore Y; Chenevier-Gobeaux C; Ekindjian OG; Kahan A; Borderie D
    Clin Chim Acta; 2006 May; 367(1-2):156-61. PubMed ID: 16458876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acetaminophen reactive intermediates target hepatic thioredoxin reductase.
    Jan YH; Heck DE; Dragomir AC; Gardner CR; Laskin DL; Laskin JD
    Chem Res Toxicol; 2014 May; 27(5):882-94. PubMed ID: 24661219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thioredoxin reductase inhibition by antitumor quinols: a quinol pharmacophore effect correlating to antiproliferative activity.
    Chew EH; Lu J; Bradshaw TD; Holmgren A
    FASEB J; 2008 Jun; 22(6):2072-83. PubMed ID: 18180330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex- and structure-specific differences in antioxidant responses to methylmercury during early development.
    Ruszkiewicz JA; Bowman AB; Farina M; Rocha JBT; Aschner M
    Neurotoxicology; 2016 Sep; 56():118-126. PubMed ID: 27456245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.